Research Corporation Technologies Incorporated v. Eli Lilly and Company

Good Law
United States Court of Appeals for the Ninth CircuitFebruary 25, 202624-4786California2,150 words

Opinion

Opinion

NOT FOR PUBLICATION FILED

UNITED STATES COURT OF APPEALS FEB 25 2026

FOR THE NINTH CIRCUIT MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS

RESEARCH CORPORATION No. 24-4786

TECHNOLOGIES INC.,

D.C. No. 4:16-cv-00191-SHR Plaintiff-Appellee, v.

MEMORANDUM*

ELI LILLY AND COMPANY,

Defendant-Appellant.

Appeal from the United States District Court for the District of Arizona Scott H. Rash, District Judge, Presiding

Argued and Submitted September 15, 2025 Phoenix, Arizona

Before: COLLINS, MENDOZA, and DESAI, Circuit Judges.

Eli Lilly and Company (“Lilly”) appeals the district court’s grant of

summary judgment to Research Corporation Technologies (“RCT”) on RCT’s

breach-of-contract claim for royalties. We have jurisdiction under 28 U.S.C.

§ 1291. Reviewing the grant of summary judgment de novo, see, e.g., Desire, LLC

v. Manna Textiles, Inc., 986 F.3d 1253, 1259 (9th Cir. 2021), we reverse and

remand.

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. I

Lilly develops and manufactures diabetes medications…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.